Dafna Capital Management LLC Dice Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $1.55 Million - $2.8 Million	-60,000 Reduced 31.99%	127,585 $5.93 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $1.67 Million - $2.07 Million	64,085 Added 51.89%	187,585 $5.37 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $889,650 - $1.9 Million	45,000 Added 57.32%	123,500 $3.85 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $1.17 Million - $1.78 Million	-78,404 Reduced 49.97%	78,500 $1.59 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $829,703 - $1.39 Million	62,904 Added 66.92%	156,904 $2.44 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $1.37 Million - $2.35 Million	94,000 New	94,000 $1.8 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.